LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
Open Access
- 3 February 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 21 (2) , e3001959
Abstract
The interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to Coronavirus Disease 2019 (COVID-19). The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary angiotensin-converting enzyme 2 (ACE2) receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was functionally restricted to SARS-CoV-2 by accessibility. We localized the interaction to the C-terminus of the S1 domain and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Levels of LRRC15 were greatly elevated by inflammatory signals in the lungs of COVID-19 patients. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence that it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19.Keywords
All Related Versions
Funding Information
- Wellcome Trust (206194)
- Wellcome Trust (215477/Z/19/Z))
- Pfizer UK (ITEN Award)
- Wellcome Trust (210688/Z/18/Z)
- Medical Research Council (MR/V011561/1)
- National Institute for Health Research (MR/V028448/1)
- Addenbrooke’s Charitable Trust, Cambridge University Hospitals
- Medical Research Council (MR/T032413/1)
- Wellcome Trust (204845/Z/16/Z)
- NHS Blood and Transplant (WPA15-02)
- Addenbrooke’s Charitable Trust, Cambridge University Hospitals
- NIHR Cambridge Biomedical Research Centre
- NIHR Cambridge Biomedical Research Centre
This publication has 89 references indexed in Scilit:
- A benchmarked protein microarray-based platform for the identification of novel low-affinity extracellular protein interactionsAnalytical Biochemistry, 2012
- Global quantification of mammalian gene expression controlNature, 2011
- Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificitiesGlycobiology, 2010
- Bioinformatics construction of the human cell surfaceomeProceedings of the National Academy of Sciences, 2009
- Tumor Antigen LRRC15 Impedes Adenoviral Infection: Implications for Virus-Based Cancer TherapyJournal of Virology, 2008
- The extracellular Leucine-Rich Repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patternsBMC Genomics, 2007
- A probability-based approach for the analysis of large-scale RNAi screensNature Methods, 2007
- Lib, transcriptionally induced in senile plaque-associated astrocytes, promotes glial migration through extracellular matrixBiochemical and Biophysical Research Communications, 2005
- A Novel Member of the Leucine-Rich Repeat Superfamily Induced in Rat Astrocytes by β-AmyloidBiochemical and Biophysical Research Communications, 2002
- Protein sequence alignments: a strategy for the hierarchical analysis of residue conservationBioinformatics, 1993